Notice2022-08460
Science Advisory Board to the National Center for Toxicological Research Advisory Committee; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 20, 2022
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA or Agency) announces a forthcoming public advisory committee meeting of the Science Advisory Board to the National Center for Toxicological Research. The general function of the committee is to provide advice and recommendations to the Agency on research being conducted at the National Center for Toxicological Research (NCTR). At least one portion of the meeting will be closed to the public.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 76 (Wednesday, April 20, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 76 (Wednesday, April 20, 2022)]
[Notices]
[Pages 23522-23523]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-08460]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2022-N-0001]
Science Advisory Board to the National Center for Toxicological
Research Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) announces a
forthcoming public advisory committee meeting of the Science Advisory
Board to the National Center for Toxicological Research. The general
function of the committee is to provide advice and recommendations to
the Agency on research being conducted at the National Center for
Toxicological Research (NCTR). At least one portion of the meeting will
be closed to the public.
DATES: The meeting will be held virtually on May 18, 2022, from 8 a.m.
to 5:55 p.m., Central Standard Time, and on May 19, 2022, from 8 a.m.
to 11:30 a.m., Central Standard Time.
ADDRESSES: Please note that due to the impact of this COVID-19
pandemic, all meeting participants will be joining this advisory
committee meeting via an online teleconferencing platform. Answers to
commonly asked questions about FDA advisory committee meetings may be
accessed at: <a href="https://www.fda.gov/advisory-committees/about-advisory-committees/common-questions-and-answers-about-fda-advisory-committee-meetings">https://www.fda.gov/advisory-committees/about-advisory-committees/common-questions-and-answers-about-fda-advisory-committee-meetings</a>. The meeting will be webcast both days and will be available
at the following link: <a href="https://fda.zoomgov.com/j/1605634800?pwd=QWlpWUpZUnZTVnZWWUIwckxMRVdZUT09">https://fda.zoomgov.com/j/1605634800?pwd=QWlpWUpZUnZTVnZWWUIwckxMRVdZUT09</a>.
[[Page 23523]]
Passcode: N5v5y*
FOR FURTHER INFORMATION CONTACT: Donna Mendrick, National Center for
Toxicological Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 32, Rm. 2208, Silver Spring, MD 20993-0002, 301-
796-8892, or FDA Advisory Committee Information Line, 1-800-741-8138
(301-443-0572 in the Washington, DC area). A notice in the Federal
Register about last minute modifications that impact a previously
announced advisory committee meeting cannot always be published quickly
enough to provide timely notice. Therefore, you should always check the
Agency's website at <a href="https://www.fda.gov/AdvisoryCommittees/default.htm">https://www.fda.gov/AdvisoryCommittees/default.htm</a>
and scroll down to the appropriate advisory committee meeting link, or
call the advisory committee information line to learn about possible
modifications before coming to the meeting.
SUPPLEMENTARY INFORMATION:
Agenda: On May 18, 2022, the Science Advisory Board Chair will
welcome the participants, and the NCTR Director will provide a Center-
wide update on scientific initiatives and accomplishments during the
past year. The Science Advisory Board will be presented with an
overview of the Science Advisory Board Subcommittee Site Visit Report
and a response to this review. The Center for Biologics Evaluation and
Research, Center for Drug Evaluation and Research, Center for Devices
and Radiological Health, Center for Food Safety and Applied Nutrition,
Center for Tobacco Products, and the Office of Regulatory Affairs will
each briefly discuss their specific research strategic needs and
potential areas of collaboration.
On May 19, 2022, there will be updates from the NCTR Research
Divisions and a public comment session. Following an open discussion of
all the information presented, the open session of the meeting will
close so the Science Advisory Board members can discuss personnel
issues at NCTR.
FDA intends to make background material available to the public no
later than 2 business days before the meeting. If FDA is unable to post
the background material on its website prior to the meeting, the
background material will be made publicly available at the location of
the advisory committee meeting, and the background material will be
posted on FDA's website after the meeting. Background material is
available at <a href="https://www.fda.gov/AdvisoryCommittees/Calendar/default.htm">https://www.fda.gov/AdvisoryCommittees/Calendar/default.htm</a>. Scroll down to the appropriate advisory committee meeting
link.
Procedure: On May 18, 2022, from 8 a.m. to 5:55 p.m., Central
Standard Time, and May 19, 2022, from 8 a.m. to 11:30 a.m., Central
Standard Time, the meeting is open to the public. Interested persons
may present data, information, or views, orally or in writing, on
issues pending before the committee. Written submissions may be made to
the contact person on or before May 13, 2022. Oral presentations from
the public will be scheduled between approximately 1 p.m. and 2 p.m.
Central Standard Time. Those individuals interested in making formal
oral presentations should notify the contact person and submit a brief
statement of the general nature of the evidence or arguments they wish
to present, the names and addresses of proposed participants, and an
indication of the approximate time requested to make their presentation
on or before May 5, 2022. Time allotted for each presentation may be
limited. If the number of registrants requesting to speak is greater
than can be reasonably accommodated during the scheduled open public
hearing session, FDA may conduct a lottery to determine the speakers
for the scheduled open public hearing session. The contact person will
notify interested persons regarding their request to speak by May 6,
2022.
Closed Committee Deliberations: On May 19, 2022, from 11:30 a.m. to
12 p.m., Central Standard Time, the meeting will be closed to permit
discussion where disclosure would constitute a clearly unwarranted
invasion of personal privacy (5 U.S.C. 552b(c)(6)). This portion of the
meeting will be closed to permit discussion of information concerning
individuals associated with the research programs at NCTR.
Persons attending FDA's advisory committee meetings are advised
that the Agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
disabilities. If you require accommodations due to a disability, please
contact Donna Mendrick at least 7 days in advance of the meeting.
FDA is committed to the orderly conduct of its advisory committee
meetings. Please visit our website at <a href="https://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm">https://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm</a> for procedures
on public conduct during advisory committee meetings.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: April 15, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-08460 Filed 4-19-22; 8:45 am]
BILLING CODE 4164-01-P
</pre></body>
</html>Indexed from Federal Register on April 20, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.